The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,967,155 in first-year total cost, median $211,163.
Most frequent study sections
- Special Emphasis Panel[ZAI1 AWA-M (M1)]9
Most frequent institutions
- TEXAS A&M AGRILIFE RESEARCH1
- TEXAS TECH UNIVERSITY1
- UNIV OF MARYLAND, COLLEGE PARK1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Gold Compounds for the Topical Treatment of Trichomoniasis1R21AI119459-01 | ECKMANN, LARS | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $310,000 | ZAI1 |
| 2015 | Early Stage Discovery of Natural Products Targeting Anaerobic Protozoal Pathogen1R21AI119713-01 | CICHEWICZ, ROBERT HENRY | UNIVERSITY OF OKLAHOMA, OK | $228,000 | ZAI1 |
| 2015 | Developing Therapeutics against Giardia and Other Anaerobic Protozoa by Targeting Parasite Fatty Acyl-CoA Synthetase (ACS)1R21AI119710-01 | ZHU, GUAN | TEXAS A&M AGRILIFE RESEARCH, TX | $215,789 | ZAI1 |
| 2015 | Inhibitors of Nitro Drug Targets as Antimicrobials against Trichomonas Vaginalis1R21AI119721-01 | JOHNSON, PATRICIA JEAN | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $215,600 | ZAI1 |
| 2015 | Novel In Vitro and In Vivo Bioluminescent Assays of Giardia Cellular Functioning1R21AI119791-01 | DAWSON, SCOTT C | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $211,163 | ZAI1 |
| 2015 | Fumagillin Derivatives as Novel Antigiardiasis and Antiamebiasis Drugs1R21AI119788-01 | HERZBERG, OSNAT | UNIV OF MARYLAND, COLLEGE PARK, MD | $208,998 | ZAI1 |
| 2015 | Discovery of New Anti-amoeba Therapeutics1R21AI119782-01 | NES, WILLIAM DAVID | TEXAS TECH UNIVERSITY, TX | $208,925 | ZAI1 |
| 2015 | Lead Optimization of Bis-benzimidazole Analogs for Pathogenic Free-living Amoebae1R21AI119787-01 | KYLE, DENNIS E | UNIVERSITY OF SOUTH FLORIDA, FL | $206,081 | ZAI1 |
| 2015 | Drug Design Targeting ProRS in Anaerobic Parasites1R21AI119715-01 | MERRITT, ETHAN A | UNIVERSITY OF WASHINGTON, WA | $162,599 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.